More men treated for low T, some without evidence
By Genevra Pittman NEW YORK (Reuters Health) - The proportion of middle-aged American men being treated for low testosterone more th...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - The proportion of middle-aged American men being treated for low testosterone more th...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Men taking drugs in the fluoroquinolone family were twice as likely to suffer serious k...
Read More »
By Sarah McBride SAN FRANCISCO (Reuters) - Microsoft co-founder Bill Gates is leading a $35 million investment in ResearchGate, a Be...
Read More »
By David Morgan WASHINGTON (Reuters) - U.S. Health and Human Services Secretary Kathleen Sebelius said on Tuesday that she talked to...
Read More »(This is a corrected version of a December 20, 2012 story that was erroneously issued on June 3, 2013 without the correction informa...
Read More »By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - Some call it neurological diversity, others see it as autism's ...
Read More »By Ben Hirschler LONDON (Reuters) - AstraZeneca is ending development of a rheumatoid arthritis pill that was one of its few late-st...
Read More »WASHINGTON (Reuters) - The U.S. House of Representatives approved a bill on Monday setting out how the federal government should tra...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Using sunscreen every day may help protect against aging skin, according to a new stu...
Read More »
By Andrew M. Seaman NEW YORK (Reuters Health) - People who limit how much meat they eat and stick to mostly fruits and vegetables ar...
Read More »